CD274 and non-small cell lung carcinoma: Using multiple markers, we confirmed the identification of CSCs and we demonstrated that PD-L1+ CSCs strongly associate with an altered T-cell phenotype and especially the frequency of regulatory molecules expressing T cells in metastatic LNs of NSCLC patients.